Search results for "RICS"

showing 10 items of 14086 documents

Associations between neonatal cry acoustics and visual attention during the first year

2019

It has been suggested that early cry parameters are connected to later cognitive abilities. The present study is the first to investigate whether the acoustic features of infant cry are associated with cognitive development already during the first year, as measured by oculomotor orienting and attention disengagement. Cry sounds for acoustic analyses (fundamental frequency; F0) were recorded in two neonatal cohorts at the age of 0–8 days (Tampere, Finland) or at 6 weeks (Cape Town, South Africa). Eye tracking was used to measure oculomotor orienting to peripheral visual stimuli and attention disengagement from central stimuli at 8 months (Tampere) or at 6 months (Cape Town) of age. Only a m…

endocrine systemmedicine.medical_specialtyVisual perceptiongenetic structures515 PsychologyvauvatStimulus (physiology)Audiologyeye tracking03 medical and health sciences0302 clinical medicine3123 Gynaecology and paediatricsCognitive developmentmedicinePsychology0501 psychology and cognitive sciencesfundamental frequencyvastasyntyneetDisengagement theorytarkkaavaisuusGeneral PsychologyOriginal Researchcry05 social sciencesCognitioninfantGazeattentionCohortkatseenseurantaEye trackingkognitiivinen kehitysPsychology030217 neurology & neurosurgeryitkeminen050104 developmental & child psychology
researchProduct

HGH secretion after oral application of l-Dopa and l-Carbiodopa

1976

The stimulatory effect of L-Dopa and L-Carbidopa (Nacom) on HGH secretion was determined in 12 children of normal height aged from 6 to 14 years. Each child received a standard dose of 250 mg L-Dopa and 25 mg L-Carbidopa p.o. HGH concentration in the serum was determined at standard intervals. All subjects showed a sufficient increase of HGH. The mean value was 19.6 ng/ml. According to the maximum values of the HGH concentration the sample can be divided into two groups; the first group reached the highest values after 20--40 min, the second one after 60--90 min. On evaluation of the curve of the mean values it appears that 2 blood samples taken 40 and 90 min after the ingestion of L-Dopa a…

endocrine systemmedicine.medical_specialtybusiness.industryMean valueStimulationGeneral MedicineGrowth hormoneEndocrinologyInternal medicineCarbidopaPediatrics Perinatology and Child HealthMedicineIngestionRadiology Nuclear Medicine and imagingSecretionOral applicationbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugEuropean Journal of Pediatrics
researchProduct

Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L‐dopa/L‐carbidopa and propranolol in children of short stature

2000

In 59 otherwise healthy children of short stature, the simultaneous response of growth hormone, cortisol and plasma adrenocorticotropin (ACTH) to L-dopa/L-carbidopa and propranolol at 45 and 90 min after administration were investigated. A growth hormone response of 10 microg/l or higher was considered positive. The definition of a positive cortisol response included either a hormone increase of at least 193 nmol/l or a peak hormone level of at least 497 nmol/l. The ACTH increase had to be fourfold above 11 pmol/l to be considered positive. In the 59 investigated children, the median basal growth hormone levels increased from 1.35 microg/l to 18.05 microg/l and 10.15 microg/l at 45 and 90 m…

endocrine systemmedicine.medical_specialtybusiness.industryStimulationGeneral MedicinePropranololGrowth hormoneSimultaneous stimulationShort statureBasal (phylogenetics)EndocrinologyInternal medicineCarbidopaPediatrics Perinatology and Child HealthMedicinemedicine.symptombusinesshormones hormone substitutes and hormone antagonistsHormonemedicine.drugActa Paediatrica
researchProduct

Ovarian size and blood flow in women with polycystic ovary syndrome (PCOS) and their correlations with some endocrine parameters

2005

Objective: To determine how common polycystic ovarian morphology may be in women given the clinical diagnosis of polycystic ovary syndrome (PCOS) based on chronic anovulation and hyperandrogenism and whether certain hormonal factors correlate with ovarian morphology and blood flow. Design: Prospective study. Setting: Two academic endocrinology centers in Italy. Patient(s): Three hundred twenty-six women with PCOS and 50 age-matched and weight-matched ovulatory women. Intervention(s): Ultrasound assessment of ovarian morphology in patients and controls and ovarian blood flow and fasting hormone levels in a subset of 50 patients and matched controls. Main Outcome Measure(s): Ovarian morpholog…

endocrine systemmedicine.medical_specialtyendocrine system diseasesmedicine.drug_classPolycystic ovary syndrome ovarian size blood flow insulin testosterone inhibin Bmedicine.medical_treatmentHemodynamicsOvaryBiologyStatistics NonparametricAnovulationInsulin resistanceEndocrine GlandsInternal medicinemedicineHumansProspective StudiesGonadal Steroid Hormonesendocrine parametersAnalysis of VarianceInsulinOvaryHyperandrogenismObstetrics and GynecologyOrgan Sizemedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsmedicine.anatomical_structureEndocrinologyReproductive MedicineRegional Blood FlowEstrogenpolycystic ovary syndromeFemaleHyperandrogenismpolycystic ovary syndrome; endocrine parametersAnovulation
researchProduct

Clinical and metabolic findings in a 6-year-old boy with a Leydig cell tumour

2011

Aim:  To analyse the urinary steroid metabolome in a boy who had true precocious puberty after a Leydig cell tumour. Method:  Case report and detailed description of clinical and metabolic findings in a 7-year-old-boy with a Leydig cell tumour. Results:  Before surgery, the urinary steroid metabolome showed an activation of an alternative route to gonadal androgens independent of dehydroepiandrosterone (DHEA). After surgery, the boy entered true precocious puberty. Under leuprolide acetate treatment, clinical and laboratory findings normalized. Conclusion:  Central precocious puberty after precocious pseudopuberty may be more common than expected and should be considered in children with pe…

endocrine systemmedicine.medical_specialtymedicine.drug_classbusiness.industryUrinary systemCentral precocious pubertyDehydroepiandrosteroneGeneral MedicineAndrogenLeydig cell tumourmedicine.diseasePrecocious pseudopubertyBack doorEndocrinologyInternal medicinePediatrics Perinatology and Child HealthmedicineMetabolomebusinessActa Paediatrica
researchProduct

Thyrotrophin-releasing hormone-a lactation-promoting agent?

1991

Objective— To study the lactational and hormonal responses to nasal administration of thyrotrophin-releasing hormone (TRH) in puerperal women with inadequate lactation. Design— Prospective randomized double-blind placebo-controlled study. Subjects— 19 puerperal women with inadequate lactation (<50% of normal milk yield) on the 5th day postpartum. Interventions— 10 women were allocated to receive TRH administered by a nasal spray of 1 mg, four times daily, between suckling episodes, for 10 consecutive days starting on day 6 postpartum. Nine women were allocated to receive placebo sprays. Main outcome measures— Daily milk yield, serum levels of prolactin and thyroid hormones. Results— Before …

endocrine systemmedicine.medical_specialtymedicine.medical_treatmentThyrotropinLactation DisordersPeptide hormonePlaceboDrug Administration ScheduleDouble-Blind MethodThyroid-stimulating hormoneLactationInternal medicinemedicineHumansProspective StudiesThyrotropin-Releasing HormoneAdministration IntranasalTriiodothyroninebusiness.industryObstetrics and GynecologyProlactinProlactinThyroxinemedicine.anatomical_structureEndocrinologyNasal sprayTriiodothyronineFemalebusinesshormones hormone substitutes and hormone antagonistsHormoneBJOG: An International Journal of Obstetrics and Gynaecology
researchProduct

A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiog…

2021

Dopamine receptor 2 agonists (D2-ags) have been shown to reduce the size of tumors by targeting aberrant angiogenesis in pathological tissue. Because of this, the use of a D2-ag was inferred for endometriosis treatment. When assayed in mouse models however, D2-ags have been shown to cause a shift of the immature vessels towards a more mature phenotype but not a significant reduction in the amount of vascularization and size of lesions. These has raised concerns on whether the antiangiogenic effects of these compounds confer a therapeutic value for endometriosis. In the belief that antiangiogenic effects of D2-ags in endometriosis were masked due to non-optimal timing of pharmacological inte…

endometriosis0301 basic medicineAgonistAngiogenesismedicine.drug_classEndometriosisdopamine agonistMedicine (miscellaneous)Dopamine agonistArticleGeneral Biochemistry Genetics and Molecular BiologyLesion03 medical and health sciencesheterologous mouse model0302 clinical medicineIn vivoCabergolinemedicinelcsh:QH301-705.5030219 obstetrics & reproductive medicinebusiness.industryantiangiogenicmedicine.disease030104 developmental biologylcsh:Biology (General)anti-VEGFDopamine receptorCancer researchmedicine.symptombusinessmedicine.drugBiomedicines
researchProduct

Inhibition of KIF20A by BKS0349 reduces endometriotic lesions in a xenograft mouse model

2019

AbstractSeveral studies have suggested a possible etiological association between ovarian endometriosis and ovarian cancer. Evidence has shown that KIF20A overexpression might confer a malignant phenotype to ovarian tumors by promoting proliferation and inhibiting apoptosis. However, no data about the role of KIF20A in endometriosis have been described. In this study, the human endometrium (n = 4) was transfected by mCherry adenovirus and intraperitoneally implanted in mice. Subsequently, mice were divided in three groups (n = 8/group) that were treated with Vehicle, BKS0349 (KIF20A-antagonist) or cabergoline (dopamine receptor agonist) for 21 days. mCherry-labeled endometriotic lesions wer…

endometriosisEmbryologyCabergolineEndometriosisEndometriosisKinesinsMice NudeApoptosisBiologyPeritoneal DiseasesEndometriumAndrologyEndometriumMiceGeneticsmedicineAnimalsHumansKIF20AMolecular BiologyCell ProliferationTUNEL assayOptical ImagingapoptosisObstetrics and GynecologyCell BiologyCell cyclemedicine.diseaseDisease Models Animalcell proliferationmedicine.anatomical_structureReproductive MedicineApoptosisOvarian EndometriosisHeterograftsImmunohistochemistrycell cycleFemaleOvarian cancerDevelopmental BiologyMolecular Human Reproduction
researchProduct

Guidelines for biomarker discovery in endometrium: correcting for menstrual cycle bias reveals new genes associated with uterine disorders

2021

Abstract Transcriptomic approaches are increasingly used in reproductive medicine to identify candidate endometrial biomarkers. However, it is known that endometrial progression in the molecular biology of the menstrual cycle is a main factor that could affect the discovery of disorder-related genes. Therefore, the aim of this study was to systematically review current practices for considering the menstrual cycle effect and to demonstrate its bias in the identification of potential biomarkers. From the 35 studies meeting the criteria, 31.43% did not register the menstrual cycle phase. We analysed the menstrual cycle effect in 11 papers (including 12 studies) from Gene Expression Omnibus: t…

endometriosisEmbryologyUterine fibroidsmedia_common.quotation_subjectmenstrual cycle progressionEndometriosisBiologyBioinformaticsEndometriumdifferential expressionEndometriumendometrial pathologiesGeneticsmedicineHumansuterine fibroidsBiomarker discoveryMolecular Biologytranscriptomic analysisMenstrual CycleMenstrual cycleOriginal Researchrecurrent implantation failuremedia_commonUterine Diseasesrecurrent pregnancy lossObstetrics and GynecologyCell Biologymedicine.diseaseAcademicSubjects/MED00905Uterine DisorderMenstrual cycle phaseconfounding variablemedicine.anatomical_structureReproductive Medicinegene expressionOvarian EndometriosisFemaleTranscriptomeDevelopmental BiologyMolecular Human Reproduction
researchProduct

Influence of nerve growth factor in endometriosis-associated symptoms

2011

To investigate the role of the nerve growth factor (NGF) in the development of dysmenorrhea/pelvic pain in patients with endometriosis, we performed a prospective, clinical, blind study. Peritoneal fluids (PFs) were obtained from patients with histologically proven endometriosis. Patients with endometriosis were divided into 7 different groups depending on their preoperative pain score and symptomatology: patients with no pain, patients with minimal pain (dysmenorrhea, pelvic pain, or both), and patients with severe pain (dysmenorrhea, pelvic pain, or both) and were used for the neuronal growth assay with cultured chicken dorsal root ganglia (DRG) and for Western blot analyses. Dorsal root …

endometriosisEndometriosisFluorescent Antibody TechniqueChick EmbryoGastroenterologypain generation of endometriosis-related symptomSeverity of Illness Indexendometriosis; pelvic pain; sensory nerve fibersGAP-43 ProteinGanglia SpinalGermanyNerve Growth FactorAscitic FluidProspective StudiesEndometriosiProspective cohort studyCells CulturedPain MeasurementNeuronsbiologymedicine.diagnostic_testObstetrics and Gynecologypelvic painMiddle AgedBlotAnesthesiaFemalemedicine.symptomNeurotrophinHumanAdultmedicine.medical_specialtyCalcitonin Gene-Related PeptideBlotting Westernsensory nerve fibersCalcitonin gene-related peptidesensory nerve fiberYoung AdultWestern blotDysmenorrheaInternal medicinemedicineAnimalsHumansbusiness.industryAnimalPelvic painNeuronmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaProspective StudieNerve growth factorbiology.proteinbusiness
researchProduct